Modulight’s financial reporting and Annual General Meeting in 2022
MODULIGHT CORPORATION, COMPANY RELEASE 29 DECEMBER 2021 AT 2:00 P.M. FINNISH TIME
During the year 2022, Modulight will publish the financial information as follows:
· 4Q21 Business Review (1-12/2021): 15 March 2022
· Financial Statement Bulletin for 2021: 15 March 2022
· 1Q22 Business Review (1–3/2022): 28 April 2022
· 2Q22 Business Review (1–6/2022): 19 August 2022
· 1H22 Half-year Financial Report (1–6/2022): 19 August 2022
· 3Q22 Business review (1–9/2022): 20 October 2022
The Financial Statements Bulletin, Half-year Financial Report and Q1/Q3 Business Reviews will be published at approximately 08.00 Finnish time on the said dates.
Report by the Board of Directors and Financial Statements 2021
The report of the Board of Directors and the financial statements for the financial year 2021 will be published on the company's website at https://www.modulight.com/reports-presentations/ on week 11 / 2022.
Annual General Meeting 2022
The Annual General Meeting is scheduled to be held on 2 May 2022. The meeting will be convened later by the Board of Directors of Modulight Corporation.
For further information, please contact:
IR: Ulla Haapanen m. +358 40 830 4676
Email: [email protected]
Certified Adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358
www.modulight.com
Twitter: @modulight, @orsila
Modulight in brief
Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight's products are used worldwide by many Fortune 500 companies, international pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.